Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. (Q50453985)
Jump to navigation
Jump to search
scientific article published on 25 June 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. |
scientific article published on 25 June 2014 |
Statements
1 reference
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. (English)
1 reference
John T Reilly
Mary Frances McMullin
Philip A Beer
Nauman Butt
Eibhlin Conneally
Andrew S Duncombe
George Mikhaeel
Steven Knapper
Ruben A Mesa
Claire N Harrison
25 June 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference